D C Berwick
Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of beta-catenin signaling
Berwick, D C; Javaheri, B; Wetzel, A; Hopkinson, M; Nixon-Abell, J; Granno, S; Pitsillides, A A; Harvey, K
Authors
B Javaheri
A Wetzel
M Hopkinson
J Nixon-Abell
S Granno
A A Pitsillides
K Harvey
Citation
Berwick, D. C., Javaheri, B., Wetzel, A., Hopkinson, M., Nixon-Abell, J., Granno, S., …Harvey, K. (2017). Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of beta-catenin signaling. Molecular Neurodegeneration, 12(9), https://doi.org/10.1186/s13024-017-0153-4
Journal Article Type | Article |
---|---|
Acceptance Date | Jan 6, 2017 |
Publication Date | Jan 19, 2017 |
Deposit Date | Apr 8, 2017 |
Publicly Available Date | Nov 21, 2020 |
Journal | Molecular Neurodegeneration |
Publisher | BioMed Central |
Peer Reviewed | Peer Reviewed |
Volume | 12 |
Issue | 9 |
DOI | https://doi.org/10.1186/s13024-017-0153-4 |
Public URL | https://rvc-repository.worktribe.com/output/1393772 |
Files
10752.pdf
(1.6 Mb)
PDF
You might also like
Fracture-induced pain-like behaviours in a femoral fracture mouse model
(2021)
Journal Article